P gene RT region mutations of hepatitis B virus in 74 patients with lamivudine-resistance

( views:449, downloads:0 )
ZHANG Zhong-dong(No.2 Internal Medicine Department, The Sixth People's Hospital of Hangzhou , Hongzhou 310014, China)
LIU Hui-min(No.2 Internal Medicine Department, The Sixth People's Hospital of Hangzhou , Hongzhou 310014, China)
Lü Tie-feng(No.2 Internal Medicine Department, The Sixth People's Hospital of Hangzhou , Hongzhou 310014, China)
Journal Title:
Volume 1, Issue 04, 2008
Key Word:
Hepatitis B virus;Lamivudine;Mutation;Viral load

Abstract: Objective To investigate mutations at HBV P gene RT region in lamivudine-resistant patients. Methods Serum samples were collected from 74 hepatitis B patients resistant to lamivudine. HBV P gene RT region was amplified by PCR, and the PCR products were directly sequenced and the viral loads were detected. Results There were 7 forms of mutations in 74 patients harboring YMDD mutations detected in this study. The common mutation forms were rtM204V/rtL180M, rtM204I and rtM204I/rtL180M. The most frequent mutation positions were rtM204I (38.7%), rtM204V (21.8%), rtL180M (38.7%) and rtV173L (0.8%). Conclusions The mutation forms and positions of lamivudine-resistant viral strains are complex. Common mutation forms and positions are not directly correlated with the viral load, but some novel forms may be associated with it.

  • [1]Expert group for the clinical use of lamivudine.Lamivudine treatment consensus from relative experts in 2004.Zhonghua Ganzangbing Zazhi,2004,12(7):425-428.拉米夫定临床应用专家组.2004年拉米夫定临床应用专家共识.中华肝脏病杂志,2004,12(7):425-428.
  • [2]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The progamme of prevention and cure for viral hepatitis.Zhonghua Ganzangbing Zazhi,2000,8(6):324-329.中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案.中华肝脏病杂志,2000,8(6):324-329.
  • [3]Keeffe EB,Dieterieh DT,Pawlotsky JM,et al.Chronic hepatitis B:preventing,detecting,and managing viral resistance.Clin Gastroenterol Hepatol,2008,6(3):268-274.
  • [4]Luo XJ,Xu KQ.Rapid method for hepatitis B vires DNA extraction from serum for quantitative PCR amplification.Zhongguo Xiandai Yixue Zazhi,2004,14(18):124-126.罗心静,徐克前.血清乙肝病毒DNA的快速提取及定量PCR测定中应用的探讨.中国现代医学杂志,2004,14(18):124-126.
  • [5]Hou JL,Sun J,Wang C.Retrospective and perspectives in HBV drug-resistant variations.Zhonghua Ganzangbing Zazhi,2007,15(1):1-3.侯金林,孙剑,王程.乙型肝炎病毒耐药变异研究的回顾与展望.中华肝脏病杂志,2007,15(1):1-3.
  • [6]Lok AS,McMahon BJ.Chronic hepatitis B.Hepatology,2001,34(6):1225-1241.
  • [7]Benhamou Y,Bechet M,Thihanh V,et al.long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.Hepatology,1999,30(5):1302-1306.
  • [8]Beck CT,Tillmann HL,Torresi J,et al.Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.Gastronterology,2002,122(2):264-273.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn